SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001047469-20-003278
Filing Date
2020-06-01
Accepted
2020-06-01 06:02:40
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 a2241741z424b5.htm 424B5 516148
2 G69145.JPG g69145.jpg GRAPHIC 25671
  Complete submission text file 0001047469-20-003278.txt   552711
Mailing Address 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406
Business Address 56 FITZWILLIAM SQUARE DUBLIN L2 2 (610) 816-6640
Nabriva Therapeutics plc (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-223739 | Film No.: 20930812
SIC: 2834 Pharmaceutical Preparations